Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection [Phase 1, Phase 2]

View source ↗

Summary

This update describes an ongoing Phase 1/2 clinical trial evaluating CT041 autologous CAR T-cell therapy for gastric adenocarcinoma, gastroesophageal junction a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• CT041 Autologous CAR T-cell Injection

Snippet

Sponsor: CARsgen Therapeutics Co., Ltd. | Conditions: Gastric Adenocarcinoma, Pancreatic Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING